BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32912837)

  • 1. Prevalence and outcomes of thrombotic and hemorrhagic complications in pediatric acute promyelocytic leukemia in a tertiary Brazilian center.
    de Albuquerque Antunes A; Breviglieri CNM; Celeste DM; Garanito MP; Cristofani LM; Carneiro JDA
    Hematol Transfus Cell Ther; 2021; 43(3):309-312. PubMed ID: 32912837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia-a single center experience in 34 patients.
    Dally N; Hoffman R; Haddad N; Sarig G; Rowe JM; Brenner B
    Thromb Res; 2005; 116(2):109-14. PubMed ID: 15907524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia.
    Chang H; Kuo MC; Shih LY; Dunn P; Wang PN; Wu JH; Lin TL; Hung YS; Tang TC
    Eur J Haematol; 2012 Apr; 88(4):321-8. PubMed ID: 22221178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of empirical treatment for newly diagnosed acute promyelocytic leukemia combined with disseminated intravascular coagulation].
    Yang H; Zhu CY; Wang QS; Niu JH; Zhang Q; Zhu HY; Yao ZL; Xu YY; Jing Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):315-22. PubMed ID: 24762998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of FDP/FIB and D-dimer/FIB ratios in predicting high-risk APL-related thrombosis.
    Bai Y; Shi M; Yang X; Zhang W; Yang R; Wei X; Wei X; Duan L; Wang C; Mi R; Waqas Ahmed HA; Huo L; Chen Y; Xu F; Wu D; Sun K
    Leuk Res; 2019 Apr; 79():34-37. PubMed ID: 30831481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute promyelocytic leukemia-associated thrombosis.
    Chang H; Kuo MC; Shih LY; Wu JH; Lin TL; Dunn P; Tang TC; Hung YS; Wang PN
    Acta Haematol; 2013; 130(1):1-6. PubMed ID: 23343825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABO identical and washed blood transfusions as candidate strategies to reduce early mortality in acute promyelocytic leukemia.
    Sahai T; Henrichs K; Refaai M; Heal JM; Kirkley SA; Schmidt AE; Mendler JH; Masel D; Liesveld J; Aquina C; Blumberg N
    Leuk Res; 2017 Nov; 62():1-3. PubMed ID: 28963906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Blood coagulation parameters in children with acute promyelocytic leukemia, their changes during all-trans retinoic acid treatment, and causes of hemorrhagic and thrombotic events].
    Lipaĭ NV
    Klin Lab Diagn; 2011 Feb; (2):29-32. PubMed ID: 21509985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clot waveform analysis in acute promyelocytic leukemia.
    Terras M; El Borgi W; Betbout W; Jaied R; Lakhal FB; Salem SF; Ghali O; Gouider E
    Blood Coagul Fibrinolysis; 2024 Jan; 35(1):27-31. PubMed ID: 37994627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulation abnormalities, bleeding, thrombosis, and management of patients with acute liver failure in Australia and New Zealand.
    Warrillow S; Fisher C; Tibballs H; Bailey M; McArthur C; Lawson-Smith P; Prasad B; Anstey M; Venkatesh B; Dashwood G; Walsham J; Holt A; Wiersema U; Gattas D; Zoeller M; Garcia Alvarez M; Bellomo R
    J Gastroenterol Hepatol; 2020 May; 35(5):846-854. PubMed ID: 31689724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of factors affecting hemorrhagic diathesis and overall survival in patients with acute promyelocytic leukemia.
    Lee HJ; Kim DH; Lee S; Koh MS; Kim SY; Lee JH; Lee S; Oh SY; Han JY; Kim HJ; Kim SH
    Korean J Intern Med; 2015 Nov; 30(6):884-90. PubMed ID: 26552464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the management of coagulopathy in acute promyelocytic leukemia.
    Sanz MA; Montesinos P
    Thromb Res; 2020 Jul; 191 Suppl 1():S63-S67. PubMed ID: 32736781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of Chinese disseminated intravascular coagulation scoring system (version 2017) in patients with acute promyelocytic leukemia].
    Huang YT; Liu XF; Fu RF; Chen YF; Liu W; Xue F; Zhang L; Yang RC
    Zhonghua Xue Ye Xue Za Zhi; 2018 Jun; 39(6):480-484. PubMed ID: 30032565
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk factors for early hemorrhagic and thrombotic complications after kidney transplantation.
    Pawlicki J; Cierpka L; Król R; Ziaja J
    Transplant Proc; 2011 Oct; 43(8):3013-7. PubMed ID: 21996213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of acute promyelocytic leukemia in a patient with prosthetic heart valves: a case report and review of the literature.
    Haghighat S; Rezvani A; Mokhtari M
    J Med Case Rep; 2021 May; 15(1):260. PubMed ID: 33941263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid.
    Escudier SM; Kantarjian HM; Estey EH
    Leuk Lymphoma; 1996 Feb; 20(5-6):435-9. PubMed ID: 8833399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New onset acute promyelocytic Leukemia during pregnancy: report of 2 cases.
    Li H; Han C; Li K; Li J; Wang Y; Xue F
    Cancer Biol Ther; 2019; 20(4):397-401. PubMed ID: 30453810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperfibrinolysis Is an Important Cause of Early Hemorrhage in Patients with Acute Promyelocytic Leukemia.
    Song YH; Qiao C; Xiao LC; Zhang R; Lu H-
    Med Sci Monit; 2018 May; 24():3249-3255. PubMed ID: 29771870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bleeding and thrombosis in acute promyelocytic leukemia.
    Choudhry A; DeLoughery TG
    Am J Hematol; 2012 Jun; 87(6):596-603. PubMed ID: 22549696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Thrombohemorrhagic Syndromes (THS) in hematologic malignancies.
    Falanga A; Rickles FR
    Hematology Am Soc Hematol Educ Program; 2007; ():165-71. PubMed ID: 18024625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.